The company is reducing the cost of its 2.5 milligram and 5 milligram Zepbound vials to $349 and $499 a month, respectively, according to a statement. That’s about $50 less than current prices.... Read More
Indianapolis-based Gate Neurosciences plans to acquire a fellow biotech startup, Menlo Park, California-based Boost Neuroscience, the companies announced Wednesday.... Read More
A West Lafayette-based life sciences diagnostic company has received federal regulatory clearance for its first product aimed at early detection of pancreatic cancer.... Read More
Novilytic, which makes products designed to give real-time alerts to pharmaceutical companies if a batch of drugs under development is contaminated, has signed an exclusive distribution deal with Pennsylvania-based Avantor.... Read More
Indianapolis-based Eli Lilly and Co. reported fourth-quarter earnings early Thursday morning that topped Wall Street expectations, largely driven by sales of blockbuster medications including weight-loss drug Mounjaro.... Read More
OrthoWorx tapped Westfield-based iXplore to immerse students in virtual reality to experience what an orthopedic job might be like.... Read More
Warsaw-based Zimmer Biomet is looking to acquire a medical device company headquartered in Englewood, Colorado. The proposed deal for Paragon 28, which specializes in foot and ankle orthopedics, is valued at $1.2 billion. ... Read More
Indiana University School of Medicine scientists have been awarded a $3.2 million federal grant for research that could expand stem cell therapies and lead to new treatments for leukemia and other blood disorders.... Read More
Pete Yonkman, president of Cook Group and Cook Medical, sees initiatives like the new Indiana University IU Launch Accelerator for Biosciences, or IU LAB, as key to helping Hoosier health care companies stay on the cutting edge.... Read More
In late 2023, Warsaw-based OrthoPediatrics announced the creation of its Specialty Bracing division, focused on developing new pediatric brace products. Just over a year later, the company announced an expansion of the division with three specialty clinics.... Read More
The Young Institute Pharmaceutical Manufacturing Consortium will focus on the manufacturing of sterile injectables and "innovative aseptic manufacturing technology," the university said Friday.... Read More
The Indianapolis-based drugmaker will acquire Scorpion’s STX-478, a once-daily oral treatment in early trials for breast cancer and other advanced solid tumors. The therapy is designed to target PI3Ka gene mutations.... Read More
The health care giant said Monday that it will pay $132 in cash for each share of Intra-Cellular. That represents a 39% premium to Intra-Cellular’s closing price of $94.87 on Friday.... Read More
Indiana Secretary of Commerce David Rosenberg, president and CEO of the Indiana Economic Development Corp., has been named the inaugural president and CEO of the Indiana University Launch Accelerator for Biosciences in Indianapolis, IU announced Thursday.... Read More
Kosali Simon, a professor at IU Bloomington’s O’Neill School of Public and Environmental Affairs and a Regenstrief research scientist, will focus on identifying and addressing barriers to equitable and effective care for this growing population of patients.... Read More
Indiana University received its largest grant to support research and development, and that money will go towards a new biosciences initiative. The $138 million grant will establish the IU Launch Accelerator for Biosciences at the 16 Tech Innovation District.... Read More
With the deal done, Novo Holdings said it will move forward with plans to sell three of Catalent’s fill-finish sites—including one in Bloomington—to subsidiary Novo Nordisk.... Read More
Indiana University has landed a $138 million grant from the Lilly Endowment that will fund construction of a state-of-the-art facility to drive advancements and commercialization in biosciences and develop talent in the sector.... Read More
Roche Diagnostics says it has developed blood tests to help rule out a diagnosis of Alzheimer’s disease in the broad population, thus narrowing who might be suffering from the disease.... Read More
Under pressure to keep up with soaring demand for drug treatments for obesity, diabetes and other diseases, Eli Lilly and Co. is planning a $3 billion expansion of a Wisconsin manufacturing plant that it acquired earlier this year.... Read More
